Increased screening and early treatment could be exactly what is needed to drive preventative and patient-specific care for type 1 diabetes (T1D), says GlobalData. However, the leading data and analytics company highlights the difficulties being faced in the implementation of T1D screening. On one side, key opinion leaders (KOLs) in the EU and US believe […]

The sepsis and septic shock market is expected to experience significant growth from $3.48 billion in 2020 to $7.5 billion by 2030 across the seven major markets (7MM*) at a compound annual growth rate (CAGR) of 8%, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Sepsis: Global Drug Forecast and Market […]

Moving towards digitalization in healthcare was on many governments’ agendas prior to the COVID-19 pandemic, but issues with the legislative landscape, reimbursement, and acceptance prevented telehealth from being fully integrated into healthcare systems, says GlobalData. The leading data and analytics company notes that, while telemedicine showcased its potential to become an essential element of modern […]

Following the news that Pfizer CEO Albert Bourla called people who spread misinformation on COVID-19 vaccines ‘criminals’, Emily Martyn, MPH, Healthcare Analyst at GlobalData, a leading data and analytics company, offers her view: “It is understandable that the pharmaceutical industry is frustrated, however, it is important to remember that the unvaccinated community, including anti-vaxxers, are […]

At the end of September, results were presented at the European Academy of Dermatology and Venereology (EADV) Congress from a study exploring patterns in the rare skin disease hidradenitis suppurativa (HS). Currently, effective therapies for the disease are limited, leading to great unmet need for better treatment options. HS-specific patterns in patients’ skin and gut microbiomes in this study suggest that similar to psoriasis (PsO), HS may be a good candidate indication for […]